Literature DB >> 25645888

The alternative complement component factor B regulates UV-induced oedema, systemic suppression of contact and delayed hypersensitivity, and mast cell infiltration into the skin.

Scott N Byrne1, Kirsten J L Hammond, Carling Y-Y Chan, Linda J Rogers, Clare Beaugie, Sabita Rana, Felix Marsh-Wakefield, Joshua M Thurman, Gary M Halliday.   

Abstract

Ultraviolet (UV) wavelengths in sunlight are the prime cause of skin cancer in humans with both the UVA and UVB wavebands making a contribution to photocarcinogenesis. UV has many different biological effects on the skin that contribute to carcinogenesis, including suppression of adaptive immunity, sunburn and altering the migration of mast cells into and away from irradiated skin. Many molecular mechanisms have been identified as contributing to skin responses to UV. Recently, using gene set enrichment analysis of microarray data, we identified the alternative complement pathway with a central role for factor B (fB) in UVA-induced immunosuppression. In the current study we used mice genetically deficient in fB (fB-/- mice) to study the functional role of the alternative complement pathway in skin responses to UV. We found that fB is required for not only UVA but also UVB-induced immunosuppression and solar-simulated UV induction of the oedemal component of sunburn. Factor B-/- mice had a larger number of resident skin mast cells than control mice, but unlike the controls did not respond to UV by increasing mast cell infiltration into the skin. This study provides evidence for a function role for fB in skin responses to UV radiation. Factor B regulates UVA and UVB induced immunosuppression, UV induced oedema and mast cell infiltration into the skin. The alternative complement pathway is therefore an important regulator of skin responses to UV.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645888     DOI: 10.1039/c4pp00399c

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  3 in total

1.  The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury.

Authors:  Saravanakumar Selvaraj; Jung-Hwa Oh; Reinhard Spanel; Florian Länger; Hyoung-Yun Han; Eun-Hee Lee; Seokjoo Yoon; Jürgen Borlak
Journal:  Oncotarget       Date:  2017-09-23

2.  The Immunogenetics of Melanoma.

Authors:  Farzaneh Darbeheshti
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma.

Authors:  Chenglu He; Ya Li; Ruixian Zhang; Jing Chen; Xingxing Feng; Yong Duan
Journal:  Oncol Lett       Date:  2021-04-19       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.